Clinical syndromes of alcoholic liver disease

被引:78
作者
Adachi, M [1 ]
Brenner, DA [1 ]
机构
[1] Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA
关键词
alcoholic liver disease; steatosis; steatohepatitis; fibrosis;
D O I
10.1159/000090173
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Aims: Alcoholic liver disease continues to be a major health problem with respect to both morbidity and mortality. To understand the clinical syndromes of alcoholic liver disease, this review highlights the papers on both clinical and basic research of alcoholic liver disease, especially on steatosis, alcoholic hepatitis and fibrosis. Methods: The various forms of alcoholic liver disease are described, and knowledge about the clinical and pathophysiological features of different stages of alcoholic liver disease are summarized. Results: Clinical studies combined with basic research have established a spectrum of alcoholic liver disease from steatosis to steatohepatitis, fibrosis, and cirrhosis. New insights into the pathogenesis of alcoholic liver disease include the key roles of the excess production of cytokines, reactive oxygen species, and the shortage of protective mediators, including adiponectin. Conclusion: These new insights will lead to new specific therapies for the treatment of alcoholic hepatitis and alcoholic liver fibrosis. Copyright (C) 2005 S. Karger AG, Basel.
引用
收藏
页码:255 / 263
页数:9
相关论文
共 80 条
  • [1] Role of mitochondria in alcoholic liver injury
    Adachi, M
    Ishii, H
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 2002, 32 (06) : 487 - 491
  • [2] ANTIBIOTICS PREVENT LIVER-INJURY IN RATS FOLLOWING LONG-TERM EXPOSURE TO ETHANOL
    ADACHI, Y
    MOORE, LE
    BRADFORD, BU
    GAO, WS
    THURMAN, RG
    [J]. GASTROENTEROLOGY, 1995, 108 (01) : 218 - 224
  • [3] Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: A double-blind, placebo-controlled trial
    Akriviadis, E
    Botla, R
    Briggs, W
    Han, S
    Reynolds, T
    Shakil, O
    [J]. GASTROENTEROLOGY, 2000, 119 (06) : 1637 - 1648
  • [4] ALEXANDER JF, 1971, AM J GASTROENTEROL, V56, P515
  • [5] Anantharaju A, 2003, ALCOHOL RES HEALTH, V27, P257
  • [6] Nonalcoholic fatty liver disease
    Brunt, Elizabeth M.
    Wong, Vincent W. -S.
    Nobili, Valerio
    Day, Christopher P.
    Sookoian, Silvia
    Maher, Jacquelyn J.
    Bugianesi, Elisabetta
    Sirlin, Claude B.
    Neuschwander-Tetri, BrentA.
    Rinella, Mary E.
    [J]. NATURE REVIEWS DISEASE PRIMERS, 2015, 1
  • [7] [Anonymous], 1984, HEPATOLOGY, V4, p107S, DOI 10.1002/hep.1840040725
  • [8] Oxidants and antioxidants in alcohol-induced liver disease
    Arteel, GE
    [J]. GASTROENTEROLOGY, 2003, 124 (03) : 778 - 790
  • [9] Liver fibrosis
    Bataller, R
    Brenner, DA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (02) : 209 - 218
  • [10] Prevalence of and risk factors for hepatic steatosis in northern Italy
    Bellentani, S
    Saccoccio, G
    Masutti, F
    Crocè, LS
    Brandi, G
    Sasso, F
    Cristanini, G
    Tiribelli, C
    [J]. ANNALS OF INTERNAL MEDICINE, 2000, 132 (02) : 112 - 117